A new era in cancer research

Discoveries that offer hope

Cancer research at Université de Montreal and its affiliated institutions encompasses the entire discovery chain of drugs and treatments.

IRIC researchers

Researchers at the Institute for Research in Immunology and Cancer (IRIC) work to shed light on the mechanisms of cancer and speed up the discovery of new cancer therapies.

Anne MARINIER

MEDICAL CHEMISTRY

Claude PERREAULT

IMMUNOBIOLOGY

Guy SAUVAGEAU

HEMATOLOGY

Michel BOUVIER

PHARMACOLOGY

Sébastien LEMIEUX

BIOINFORMATICS

Delphine BOUILLY

BIOPHYSICS

udemnouvelles

21 January 2025

UdeM scientists are combining immersive imagery and hypnotic techniques to reduce pain and anxiety in patients who have cancer of the blood.

16 January 2025

Scientists at UdeM and its affiliated research institute IRIC have developed a new drug-discovery platform for high-risk leukemias in children – with promising results.

9 January 2025

Funded via UdeM’s Millénium Québecor incubator program, doctoral student Madline Sauvage is awarded a $6,000 bursary to found her business start-up, SenÈn, and start helping cancer patients.

17 December 2024

Marie-Pascale Pomey receives $200,000 in funding to create a platform to help people with rare cancers find reliable information and navigate the healthcare system.

All news

Partnerships that accelerate new discoveries

Our research environments are firmly interdisciplinary and have solid ties to clinical practice. This speeds up the development of cancer therapies and gives new hope to patients and their families.

A pool of renowned researchers

Our researchers work to understand the mechanisms that lead to the emergence of cancer; they and their teams develop new therapeutic approaches and new drugs to treat different forms of the disease.